Environmental and climate cardiology: some environmental issues highlighted at the annual meetings of the German Society for Cardiology (DGK) from 2007 to 2023
Herz. 2023 Nov 20. doi: 10.1007/s00059-023-05223-0. Online ahead of print.NO ABSTRACTPMID:37985515 | DOI:10.1007/s00059-023-05223-0 (Source: Herz)
Source: Herz - November 20, 2023 Category: Cardiology Authors: Omar Hahad Source Type: research
Urantide alleviates atherosclerosis-related liver and kidney injury via the Wnt/ β-catenin signaling pathway in ApoE(-/-) mice
CONCLUSION: Urantide could improve AS-related liver and kidney injury by antagonizing the UII/UT system, and the improvements in liver and kidney function in atherosclerotic ApoE-/- mice may be related to inhibition of the Wnt/β-catenin signalling pathway.PMID:37985514 | DOI:10.1007/s00059-023-05219-w (Source: Herz)
Source: Herz - November 20, 2023 Category: Cardiology Authors: Yu-Hang Xu Jia-Yi Xie Shen Huang Tu Wang Hai-Peng Cui Juan Zhao Source Type: research
Environmental and climate cardiology: some environmental issues highlighted at the annual meetings of the German Society for Cardiology (DGK) from 2007 to 2023
Herz. 2023 Nov 20. doi: 10.1007/s00059-023-05223-0. Online ahead of print.NO ABSTRACTPMID:37985515 | DOI:10.1007/s00059-023-05223-0 (Source: Herz)
Source: Herz - November 20, 2023 Category: Cardiology Authors: Omar Hahad Source Type: research
Heart failure: update of the ESC 2023 guidelines
Herz. 2023 Nov 14. doi: 10.1007/s00059-023-05221-2. Online ahead of print.ABSTRACTThe 2023 update of the European Society of Cardiology (ESC) guidelines recommends (class IA) the administration of sodium-glucose transporter 2 inhibitors (SGLT2i) also for patients with heart failure with preserved ejection fraction (HFpEF) and mildly reduced EF (HFmrEF). Thus, SGLT2i are the only medication that should be given to all heart failure patients for improvement of prognosis independent of left ventricular EF. The rapid administration of the fantastic four drugs and their prompt titration after a heart failure decompensation is n...
Source: Herz - November 14, 2023 Category: Cardiology Authors: Johann Bauersachs Samira Soltani Source Type: research
Chest pain and cardiovascular diseases in women : Diagnostics and treatment
Herz. 2023 Nov 6. doi: 10.1007/s00059-023-05215-0. Online ahead of print.ABSTRACTCardiovascular diseases (CVD) are the leading cause of global mortality not only in men but also in women. The incidence of CVD significantly increases in women, especially after the menopause. Sex and gender differences in the incidence, prevalence and mortality of CVD are due to hormonal, anatomical, and sociocultural differences. As part of the primary and secondary prevention of coronary heart disease (CHD), risk factors specific for women, such as autoimmune diseases and pregnancy-associated diseases (e.g., gestational diabetes and pre-ec...
Source: Herz - November 6, 2023 Category: Cardiology Authors: Janet-Jacqueline Olic Andrea Baessler Marcus Fischer Source Type: research
